← Back to Clinical Trials
Recruiting NCT06536998

NCT06536998 Exploring the Association of Imaging and Tumor Microenvironment in Liver Cancer Using Radiogenomic Approach(Radiogenomics-Liver)

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06536998
Status Recruiting
Phase
Sponsor Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Condition Liver Cancer
Study Type OBSERVATIONAL
Enrollment 150 participants
Start Date 2024-08
Primary Completion 2027-08

Trial Parameters

Condition Liver Cancer
Sponsor Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Study Type OBSERVATIONAL
Phase N/A
Enrollment 150
Sex ALL
Min Age 18 Years
Max Age N/A
Start Date 2024-08
Completion 2027-08

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

This is the prospective, observational cohort study (Radiogenomics-Liver), which aims to explore the relationship between the imaging information of liver cancer patients, tumor microenvironment and the prognosis of liver cancer patients.

Eligibility Criteria

Inclusion Criteria: 1. Patients treated for liver cancer in Wuhan Union Hospital from August 2024 to August 2027; 2. Aged \> 18 years old; 3. At least one CT scan or MRI scan before treatment; 4. Tissue biopsy pathological examination confirmed the diagnosis of the above tumors. Exclusion criteria: 1. Poor image quality; 2. Incomplete clinical data or loss of follow-up; 3. Presence of another primary malignancy other than liver cancer; 4. Unclear pathological diagnosis.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology